Control of vector-borne infectious diseases by human immunity against α-Gal

Expert Rev Vaccines. 2016 Aug;15(8):953-5. doi: 10.1080/14760584.2016.1181547. Epub 2016 May 11.
No abstract available

Keywords: Microbiota; probiotics; vaccine; vector-borne diseases; α-Gal.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / immunology*
  • Bacteria / immunology*
  • Communicable Diseases / immunology
  • Communicable Diseases / therapy*
  • Communicable Diseases / transmission
  • Disaccharides / immunology*
  • Disease Transmission, Infectious / prevention & control*
  • Disease Vectors*
  • Evolution, Molecular
  • Host-Pathogen Interactions
  • Humans
  • Probiotics / therapeutic use*
  • Vaccines / immunology
  • Vaccines / therapeutic use*

Substances

  • Antibodies
  • Disaccharides
  • Vaccines
  • galactosyl-(1-3)galactose